Drugs / placenta-derived mesenchymal stem cells
placenta-derived mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07580755 | Apr 2026 → Dec 2027 expected | — | The First Affiliated Hospital of Xinxiang Medical College | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | placenta-derived mesenchymal stem cells | “Using hydrogels containing low-doses of placenta-derived mesenchymal stem cells as wound dressings to promote wound healing in burn patients after thick skin grafting” NCT07580755 ↗ |
| Modality | Cell therapy | “placenta-derived mesenchymal stem cells” NCT07580755 ↗ |
| Route | Topical | “The gel was applied as the inner dressing evenly to the wound surface.” NCT07580755 ↗ |